Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers. Collins J, Farnsworth NL. Diabetologia 2025 Jan 23. doi: 10.1007/s00125-024-06356.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Collins J, Farnsworth NL. Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers. Diabetologia 2025 Jan 23. doi: 10.1007/s00125-024-06356.
PMID: 39847085